The FDA has only approved one anti-viral drug for emergency use so far: Remdesivir. It’s been authorized to treat only people with severe Covid cases. Drugmaker Merck is now reporting promising results from a study that tested its experimental Covid pill. CNBC’s Meg Tirrell joins ‘The News with Shepard Smith’ to discuss.
By: CNBC Television Title: Experimental Covid-19 pill shows promise in preliminary testing Sourced From: www.youtube.com/watch?v=mBOPNUK_apI
